vs
Side-by-side financial comparison of NATURES SUNSHINE PRODUCTS INC (NATR) and PagerDuty, Inc. (PD). Click either name above to swap in a different company.
PagerDuty, Inc. is the larger business by last-quarter revenue ($124.5M vs $123.8M, roughly 1.0× NATURES SUNSHINE PRODUCTS INC). PagerDuty, Inc. runs the higher net margin — 129.7% vs 3.3%, a 126.4% gap on every dollar of revenue. On growth, NATURES SUNSHINE PRODUCTS INC posted the faster year-over-year revenue change (4.7% vs 4.7%). PagerDuty, Inc. produced more free cash flow last quarter ($24.1M vs $7.6M). Over the past eight quarters, PagerDuty, Inc.'s revenue compounded faster (5.9% CAGR vs 5.6%).
Nature's Sunshine Products, Inc. also known as "NSP", is a manufacturer of dietary supplements, including herbs, vitamins, minerals, and personal care products. It is based in Lehi, Utah, with a manufacturing facility in Spanish Fork, Utah.
PagerDuty, Inc. is an American cloud computing company specializing in a SaaS incident management platform for IT operations departments.
NATR vs PD — Head-to-Head
Income Statement — Q4 FY2025 vs Q3 FY2026
| Metric | | |
|---|---|---|
| Revenue | $123.8M | $124.5M |
| Net Profit | $4.1M | $161.6M |
| Gross Margin | 72.5% | 85.3% |
| Operating Margin | 4.3% | 6.5% |
| Net Margin | 3.3% | 129.7% |
| Revenue YoY | 4.7% | 4.7% |
| Net Profit YoY | 1379.4% | 2827.7% |
| EPS (diluted) | $0.23 | $1.69 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $123.8M | $124.5M | ||
| Q3 25 | $128.3M | $123.4M | ||
| Q2 25 | $114.8M | $119.8M | ||
| Q1 25 | $113.2M | $121.4M | ||
| Q4 24 | $118.2M | $118.9M | ||
| Q3 24 | $114.6M | $115.9M | ||
| Q2 24 | $110.6M | $111.2M | ||
| Q1 24 | $111.0M | $111.1M |
| Q4 25 | $4.1M | $161.6M | ||
| Q3 25 | $5.3M | $9.6M | ||
| Q2 25 | $5.3M | $-7.2M | ||
| Q1 25 | $4.7M | $-8.8M | ||
| Q4 24 | $-321.0K | $-5.9M | ||
| Q3 24 | $4.3M | $-10.9M | ||
| Q2 24 | $1.3M | $-17.1M | ||
| Q1 24 | $2.3M | $-28.2M |
| Q4 25 | 72.5% | 85.3% | ||
| Q3 25 | 73.3% | 84.6% | ||
| Q2 25 | 71.7% | 84.0% | ||
| Q1 25 | 72.1% | 83.6% | ||
| Q4 24 | 72.0% | 83.0% | ||
| Q3 24 | 71.3% | 82.7% | ||
| Q2 24 | 71.4% | 82.6% | ||
| Q1 24 | 71.2% | 81.7% |
| Q4 25 | 4.3% | 6.5% | ||
| Q3 25 | 7.0% | 2.9% | ||
| Q2 25 | 3.7% | -8.6% | ||
| Q1 25 | 5.4% | -9.6% | ||
| Q4 24 | 3.8% | -8.7% | ||
| Q3 24 | 4.6% | -13.8% | ||
| Q2 24 | 5.1% | -19.5% | ||
| Q1 24 | 4.2% | -30.1% |
| Q4 25 | 3.3% | 129.7% | ||
| Q3 25 | 4.2% | 7.8% | ||
| Q2 25 | 4.6% | -6.0% | ||
| Q1 25 | 4.2% | -7.2% | ||
| Q4 24 | -0.3% | -5.0% | ||
| Q3 24 | 3.8% | -9.4% | ||
| Q2 24 | 1.2% | -15.4% | ||
| Q1 24 | 2.1% | -25.3% |
| Q4 25 | $0.23 | $1.69 | ||
| Q3 25 | $0.30 | $0.10 | ||
| Q2 25 | $0.28 | $-0.07 | ||
| Q1 25 | $0.25 | $-0.12 | ||
| Q4 24 | $-0.02 | $-0.07 | ||
| Q3 24 | $0.23 | $-0.14 | ||
| Q2 24 | $0.07 | $-0.26 | ||
| Q1 24 | $0.12 | $-0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $93.9M | $547.8M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $161.6M | $320.5M |
| Total Assets | $261.1M | $1.0B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $93.9M | $547.8M | ||
| Q3 25 | $95.6M | $567.9M | ||
| Q2 25 | $81.3M | $597.1M | ||
| Q1 25 | $86.5M | $570.8M | ||
| Q4 24 | $84.7M | $542.2M | ||
| Q3 24 | $78.7M | $599.3M | ||
| Q2 24 | $68.7M | $592.8M | ||
| Q1 24 | $77.8M | $571.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $484.5M | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $2.1M | $489.5M |
| Q4 25 | $161.6M | $320.5M | ||
| Q3 25 | $166.7M | $180.7M | ||
| Q2 25 | $163.7M | $145.7M | ||
| Q1 25 | $167.1M | $129.8M | ||
| Q4 24 | $161.0M | $111.6M | ||
| Q3 24 | $162.6M | $164.7M | ||
| Q2 24 | $156.4M | $174.0M | ||
| Q1 24 | $159.7M | $171.6M |
| Q4 25 | $261.1M | $1.0B | ||
| Q3 25 | $264.8M | $891.5M | ||
| Q2 25 | $254.9M | $926.8M | ||
| Q1 25 | $252.7M | $927.3M | ||
| Q4 24 | $240.9M | $866.8M | ||
| Q3 24 | $245.3M | $916.0M | ||
| Q2 24 | $235.8M | $924.0M | ||
| Q1 24 | $247.3M | $925.3M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 3.73× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 0.01× | 2.85× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $9.9M | $24.8M |
| Free Cash FlowOCF − Capex | $7.6M | $24.1M |
| FCF MarginFCF / Revenue | 6.1% | 19.3% |
| Capex IntensityCapex / Revenue | 1.9% | 0.6% |
| Cash ConversionOCF / Net Profit | 2.41× | 0.15× |
| TTM Free Cash FlowTrailing 4 quarters | $28.8M | $117.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $9.9M | $24.8M | ||
| Q3 25 | $18.5M | $34.0M | ||
| Q2 25 | $4.3M | $30.7M | ||
| Q1 25 | $2.6M | $31.4M | ||
| Q4 24 | $12.2M | $22.1M | ||
| Q3 24 | $9.6M | $35.8M | ||
| Q2 24 | $1.3M | $28.6M | ||
| Q1 24 | $2.2M | $22.2M |
| Q4 25 | $7.6M | $24.1M | ||
| Q3 25 | $16.8M | $33.1M | ||
| Q2 25 | $3.0M | $30.2M | ||
| Q1 25 | $1.5M | $30.3M | ||
| Q4 24 | $10.0M | $21.5M | ||
| Q3 24 | $7.9M | $35.1M | ||
| Q2 24 | $-2.0M | $28.2M | ||
| Q1 24 | $-1.5M | $21.2M |
| Q4 25 | 6.1% | 19.3% | ||
| Q3 25 | 13.1% | 26.8% | ||
| Q2 25 | 2.6% | 25.2% | ||
| Q1 25 | 1.3% | 24.9% | ||
| Q4 24 | 8.5% | 18.1% | ||
| Q3 24 | 6.9% | 30.3% | ||
| Q2 24 | -1.9% | 25.4% | ||
| Q1 24 | -1.4% | 19.1% |
| Q4 25 | 1.9% | 0.6% | ||
| Q3 25 | 1.3% | 0.7% | ||
| Q2 25 | 1.2% | 0.4% | ||
| Q1 25 | 1.0% | 0.9% | ||
| Q4 24 | 1.9% | 0.5% | ||
| Q3 24 | 1.5% | 0.5% | ||
| Q2 24 | 3.0% | 0.4% | ||
| Q1 24 | 3.3% | 0.9% |
| Q4 25 | 2.41× | 0.15× | ||
| Q3 25 | 3.46× | 3.55× | ||
| Q2 25 | 0.81× | — | ||
| Q1 25 | 0.55× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 2.21× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.94× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
NATR
| Other | $68.1M | 55% |
| General Health Products | $20.2M | 16% |
| Digestive Products | $13.8M | 11% |
| Cardiovascular Products | $12.1M | 10% |
| Personal Care Products | $4.4M | 4% |
| Immunity Products | $3.1M | 3% |
| Weight Management Products | $2.1M | 2% |
PD
| US | $88.8M | 71% |
| Non Us | $35.7M | 29% |
